AU2003258941A1 - Metalloproteinase inhibitors and intermediates for preparation thereof - Google Patents

Metalloproteinase inhibitors and intermediates for preparation thereof

Info

Publication number
AU2003258941A1
AU2003258941A1 AU2003258941A AU2003258941A AU2003258941A1 AU 2003258941 A1 AU2003258941 A1 AU 2003258941A1 AU 2003258941 A AU2003258941 A AU 2003258941A AU 2003258941 A AU2003258941 A AU 2003258941A AU 2003258941 A1 AU2003258941 A1 AU 2003258941A1
Authority
AU
Australia
Prior art keywords
intermediates
preparation
metalloproteinase inhibitors
metalloproteinase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003258941A
Other versions
AU2003258941A8 (en
Inventor
Balint Gabos
Michael Lundkvist
Magnus Munck Af Rosenschold
Igor Shamovsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2003258941A1 publication Critical patent/AU2003258941A1/en
Publication of AU2003258941A8 publication Critical patent/AU2003258941A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
AU2003258941A 2002-09-11 2003-09-10 Metalloproteinase inhibitors and intermediates for preparation thereof Abandoned AU2003258941A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0202692-0 2002-09-11
SE0202692A SE0202692D0 (en) 2002-09-11 2002-09-11 Compounds
PCT/SE2003/001406 WO2004024060A2 (en) 2002-09-11 2003-09-10 Metalloproteinase inhibitors and intermediates for preparation thereof

Publications (2)

Publication Number Publication Date
AU2003258941A1 true AU2003258941A1 (en) 2004-04-30
AU2003258941A8 AU2003258941A8 (en) 2004-04-30

Family

ID=20288962

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003258941A Abandoned AU2003258941A1 (en) 2002-09-11 2003-09-10 Metalloproteinase inhibitors and intermediates for preparation thereof

Country Status (3)

Country Link
AU (1) AU2003258941A1 (en)
SE (1) SE0202692D0 (en)
WO (1) WO2004024060A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100902D0 (en) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (en) 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
SE0202539D0 (en) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
CA2573185A1 (en) 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Methods for treating hepatitis c
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008507518A (en) 2004-07-22 2008-03-13 ピーティーシー セラピューティクス，インコーポレーテッド Thienopyridine for treating hepatitis C
EP2155643B1 (en) 2007-06-08 2016-08-10 MannKind Corporation Ire-1a inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2745875A (en) * 1953-06-30 1956-05-15 Hoechst Ag Preparation of nu-acylamino-phenylpropane diols
GB1117616A (en) * 1964-09-23 1968-06-19 Warner Lambert Pharmaceutical Process for preparing 1-(p-acetylphenyl)-2-(2,2-dichloroacetamido)-1,3-propanediol
TW227557B (en) * 1992-03-27 1994-08-01 Yamanouchi Pharma Co Ltd
EP1191024A1 (en) * 2000-09-22 2002-03-27 Harald Tschesche Thiadiazines and their use as inhibitors of metalloproteinases
BR0208105A (en) * 2001-03-15 2004-03-09 Astrazeneca Ab Metalloproteinase Inhibitors
SE0100903D0 (en) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds

Also Published As

Publication number Publication date
SE0202692D0 (en) 2002-09-11
WO2004024060A3 (en) 2004-06-24
WO2004024060A2 (en) 2004-03-25
AU2003258941A8 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
AU2003202263A1 (en) Roh-kinase inhibitors
AU2002228302A1 (en) Matrix metalloproteinase inhibitors
HK1077762A1 (en) INHIBITORS OF TFGβ
AU2003211093A1 (en) Inhibitors of rgs proteins
AU2003217105A1 (en) Novel of cytokine inhibitors
AU2003249477A1 (en) Heterobicylcic metalloproteinase inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
AU2003238042A1 (en) Cyclooxygenase-2 inhibitors
AU2003277674A1 (en) Novel parp inhibitors
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
AU2003230392A1 (en) Beta-secretase inhibitors
AU2003258941A1 (en) Metalloproteinase inhibitors and intermediates for preparation thereof
AU2003302588A1 (en) Phosphodiesterase 10a inhibitors
AUPS282002A0 (en) Metalloproteinase inhibitors
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2003299901A1 (en) Thrombin inhibitors
AU2003258942A1 (en) Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors
AU2003269984A1 (en) Protease inhibitors
AU2003295638A1 (en) NOVEL INHIBITORS OF Beta-LACTAMASE
AUPS096002A0 (en) Method of construction
AU2003296960A1 (en) Peptide deformylase inhibitors
AU2003256323A1 (en) Sos1 inhibitors
AU2003216848A1 (en) Deracemisation of amines
AU2002342682A1 (en) Protease inhibitors
AU2003244347A1 (en) Angiogenesis inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase